A citation-based method for searching scientific literature

Francis J Herman, Sherry Simkovic, Giulio M Pasinetti. Br J Pharmacol 2019
Times Cited: 9







List of co-cited articles
19 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression.
Naomi R Wray, Stephan Ripke, Manuel Mattheisen, Maciej Trzaskowski, Enda M Byrne, Abdel Abdellaoui, Mark J Adams, Esben Agerbo, Tracy M Air, Till M F Andlauer,[...]. Nat Genet 2018
935
22

Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis.
Raymond L Ownby, Elizabeth Crocco, Amarilis Acevedo, Vineeth John, David Loewenstein. Arch Gen Psychiatry 2006
847
22

Ustekinumab significantly improves symptoms of anxiety, depression, and skin-related quality of life in patients with moderate-to-severe psoriasis: Results from a randomized, double-blind, placebo-controlled phase III trial.
Richard G Langley, Steven R Feldman, Chenglong Han, Brad Schenkel, Philippe Szapary, Ming-Chun Hsu, Jean-Paul Ortonne, Kenneth B Gordon, Alexa B Kimball. J Am Acad Dermatol 2010
119
22

Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial.
Stephen Tyring, Alice Gottlieb, Kim Papp, Ken Gordon, Craig Leonardi, Andrea Wang, Deepa Lalla, Michael Woolley, Angelika Jahreis, Ralph Zitnik,[...]. Lancet 2006
737
22


Autoimmune diseases and severe infections as risk factors for mood disorders: a nationwide study.
Michael E Benros, Berit L Waltoft, Merete Nordentoft, Søren D Ostergaard, William W Eaton, Jesper Krogh, Preben B Mortensen. JAMA Psychiatry 2013
276
22

Amyloid burden and incident depressive symptoms in cognitively normal older adults.
Karra D Harrington, Emma Gould, Yen Ying Lim, David Ames, Robert H Pietrzak, Alan Rembach, Stephanie Rainey-Smith, Ralph N Martins, Olivier Salvado, Victor L Villemagne,[...]. Int J Geriatr Psychiatry 2017
29
22

The genetics of major depression.
Jonathan Flint, Kenneth S Kendler. Neuron 2014
286
22


Amyloid-associated depression: a prodromal depression of Alzheimer disease?
Xiaoyan Sun, David C Steffens, Rhoda Au, Marshal Folstein, Paul Summergrad, Jacqueline Yee, Irwin Rosenberg, D Mkaya Mwamburi, Wei Qiao Qiu. Arch Gen Psychiatry 2008
119
22

Body fluid cytokine levels in mild cognitive impairment and Alzheimer's disease: a comparative overview.
Frederic Brosseron, Marius Krauthausen, Markus Kummer, Michael T Heneka. Mol Neurobiol 2014
210
22

Lifetime History of Depression Predicts Increased Amyloid-β Accumulation in Patients with Mild Cognitive Impairment.
Jun Ku Chung, Eric Plitman, Shinichiro Nakajima, Tiffany W Chow, M Mallar Chakravarty, Fernando Caravaggio, Philip Gerretsen, Eric E Brown, Yusuke Iwata, Benoit H Mulsant,[...]. J Alzheimers Dis 2015
40
22

CD4+CD25+ regulatory T cell depletion modulates anxiety and depression-like behaviors in mice.
Soo-Jeong Kim, Hyojung Lee, Gihyun Lee, Sei-Joong Oh, Min-Kyu Shin, Insop Shim, Hyunsu Bae. PLoS One 2012
61
22

Stress-Induced Depressive Behaviors Require a Functional NLRP3 Inflammasome.
Elísabet Alcocer-Gómez, Cristina Ulecia-Morón, Fabiola Marín-Aguilar, Tatyana Rybkina, Nieves Casas-Barquero, Jesús Ruiz-Cabello, Bernhard Ryffel, Lionel Apetoh, François Ghiringhelli, Pedro Bullón,[...]. Mol Neurobiol 2016
84
22


Activation and regulation of the inflammasomes.
Eicke Latz, T Sam Xiao, Andrea Stutz. Nat Rev Immunol 2013
22

Depression and risk of developing dementia.
Amy L Byers, Kristine Yaffe. Nat Rev Neurol 2011
512
22

Increased hippocampal plaques and tangles in patients with Alzheimer disease with a lifetime history of major depression.
Michael A Rapp, Michal Schnaider-Beeri, Hillel T Grossman, Mary Sano, Daniel P Perl, Dushyant P Purohit, Jack M Gorman, Vahram Haroutunian. Arch Gen Psychiatry 2006
248
22

Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions.
David M Howard, Mark J Adams, Toni-Kim Clarke, Jonathan D Hafferty, Jude Gibson, Masoud Shirali, Jonathan R I Coleman, Saskia P Hagenaars, Joey Ward, Eleanor M Wigmore,[...]. Nat Neurosci 2019
433
22

Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging.
Joan Lindsay, Danielle Laurin, René Verreault, Réjean Hébert, Barbara Helliwell, Gerry B Hill, Ian McDowell. Am J Epidemiol 2002
775
11

Accuracy of brain amyloid detection in clinical practice using cerebrospinal fluid β-amyloid 42: a cross-validation study against amyloid positron emission tomography.
Sebastian Palmqvist, Henrik Zetterberg, Kaj Blennow, Susanna Vestberg, Ulf Andreasson, David J Brooks, Rikard Owenius, Douglas Hägerström, Per Wollmer, Lennart Minthon,[...]. JAMA Neurol 2014
236
11



Altered expression of synapse and glutamate related genes in post-mortem hippocampus of depressed subjects.
Vanja Duric, Mounira Banasr, Craig A Stockmeier, Arthur A Simen, Samuel S Newton, James C Overholser, George J Jurjus, Lesa Dieter, Ronald S Duman. Int J Neuropsychopharmacol 2013
164
11

TNF-alpha modulation for treatment of Alzheimer's disease: a 6-month pilot study.
Edward Tobinick, Hyman Gross, Alan Weinberger, Hart Cohen. MedGenMed 2006
154
11

Neuroimmune mechanisms of depression.
Georgia E Hodes, Veronika Kana, Caroline Menard, Miriam Merad, Scott J Russo. Nat Neurosci 2015
265
11


Treatment with an acetylcholinesterase inhibitor in Alzheimer patients modulates the expression and production of the pro-inflammatory and anti-inflammatory cytokines.
Marcella Reale, Carla Iarlori, Francesco Gambi, Claudio Feliciani, Anatolia Salone, Lucia Toma, Giovanna DeLuca, Mirella Salvatore, Pio Conti, Domenico Gambi. J Neuroimmunol 2004
94
11

Tryptophan-2,3-dioxygenase (TDO) inhibition ameliorates neurodegeneration by modulation of kynurenine pathway metabolites.
Carlo Breda, Korrapati V Sathyasaikumar, Shama Sograte Idrissi, Francesca M Notarangelo, Jasper G Estranero, Gareth G L Moore, Edward W Green, Charalambos P Kyriacou, Robert Schwarcz, Flaviano Giorgini. Proc Natl Acad Sci U S A 2016
74
11

Chronic exposure to corticosterone enhances the neuroinflammatory and neurotoxic responses to methamphetamine.
Kimberly A Kelly, Diane B Miller, John F Bowyer, James P O'Callaghan. J Neurochem 2012
55
11


Inflammation-associated depression: from serotonin to kynurenine.
Robert Dantzer, Jason C O'Connor, Marcus A Lawson, Keith W Kelley. Psychoneuroendocrinology 2011
441
11

A 6-week randomized, placebo-controlled trial of CP-316,311 (a selective CRH1 antagonist) in the treatment of major depression.
Brendon Binneman, Douglas Feltner, Sheela Kolluri, Yuanjun Shi, Ruolun Qiu, Thomas Stiger. Am J Psychiatry 2008
172
11

Hippocampal volume and depression: a meta-analysis of MRI studies.
Poul Videbech, Barbara Ravnkilde. Am J Psychiatry 2004
11

Expression of intercellular adhesion molecule 1 (ICAM-1) in Alzheimer's disease.
E M Frohman, T C Frohman, S Gupta, A de Fougerolles, S van den Noort. J Neurol Sci 1991
83
11


Altered expression of CD4(+)CD25(+) regulatory T cells and its 5-HT(1a) receptor in patients with major depression disorder.
Yi Li, Bo Xiao, Wenjing Qiu, Le Yang, Bo Hu, Xiaolin Tian, Huan Yang. J Affect Disord 2010
97
11

Toll-like receptors in the depressed and suicide brain.
Ghanshyam N Pandey, Hooriyah S Rizavi, Xinguo Ren, Runa Bhaumik, Yogesh Dwivedi. J Psychiatr Res 2014
84
11

Il10 deficiency rebalances innate immunity to mitigate Alzheimer-like pathology.
Marie-Victoire Guillot-Sestier, Kevin R Doty, David Gate, Javier Rodriguez, Brian P Leung, Kavon Rezai-Zadeh, Terrence Town. Neuron 2015
215
11

Effects of corticotrophin-releasing factor receptor 1 antagonists on amyloid-β and behavior in Tg2576 mice.
Hongxin Dong, Shirlene Wang, Ziling Zeng, Fei Li, Janitza Montalvo-Ortiz, Christopher Tucker, Shahzad Akhtar, Jingshan Shi, Herbert Y Meltzer, Kenner C Rice,[...]. Psychopharmacology (Berl) 2014
27
11

The glucocorticoid receptor: pivot of depression and of antidepressant treatment?
Christoph Anacker, Patricia A Zunszain, Livia A Carvalho, Carmine M Pariante. Psychoneuroendocrinology 2011
343
11

Serum MCP-1 levels are increased in mild cognitive impairment and mild Alzheimer's disease.
Daniela Galimberti, Chiara Fenoglio, Carlo Lovati, Eliana Venturelli, Ilaria Guidi, Barbara Corrà, Diego Scalabrini, Francesca Clerici, Claudio Mariani, Nereo Bresolin,[...]. Neurobiol Aging 2006
140
11

Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.
Ronald C Kessler, Patricia Berglund, Olga Demler, Robert Jin, Kathleen R Merikangas, Ellen E Walters. Arch Gen Psychiatry 2005
11

Systemic infections and inflammation affect chronic neurodegeneration.
V Hugh Perry, Colm Cunningham, Clive Holmes. Nat Rev Immunol 2007
665
11

Accumulation of intercellular adhesion molecule-1 in senile plaques in brain tissue of patients with Alzheimer's disease.
M M Verbeek, I Otte-Höller, J R Westphal, P Wesseling, D J Ruiter, R M de Waal. Am J Pathol 1994
82
11

Emerging tendency towards autoimmune process in major depressive patients: a novel insight from Th17 cells.
Yili Chen, Tang Jiang, Peisong Chen, Juan Ouyang, Guiyun Xu, Zhijie Zeng, Yanhong Sun. Psychiatry Res 2011
95
11



Trajectories of Depressive Symptoms Before Diagnosis of Dementia: A 28-Year Follow-up Study.
Archana Singh-Manoux, Aline Dugravot, Agnes Fournier, Jessica Abell, Klaus Ebmeier, Mika Kivimäki, Séverine Sabia. JAMA Psychiatry 2017
169
11

Glial reduction in amygdala in major depressive disorder is due to oligodendrocytes.
Massihullah Hamidi, Wayne C Drevets, Joseph L Price. Biol Psychiatry 2004
247
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.